Mobile patient communication leader to use funds to accelerate growth strategy
Scottish Equity Partners (SEP) has led an initial £3m investment in Exco InTouch, the leading provider of mobile patient communication and management solutions for the pharmaceutical and healthcare sector.
SEP has taken a minority stake in the company which will use the funds to accelerate its expansion, enabling it to take advantage of significant growth opportunities in the clinical technology sector, particularly in the emerging mobile patient communication market.
Exco InTouch, whose clients include nine of the world’s top 10 pharmaceutical businesses, has developed an innovative suite of patient-focused services which are delivered using a combination of cell-phone and internet technology. Used in clinical trials, the company’s services benefit both patients and pharmaceutical clients: supporting patient recruitment and retention; aiding compliance; and facilitating the electronic capture of patient reported outcomes data (ePRO) during clinical trials and in Late Phase observational studies.
Exco InTouch, which was founded in 2004 by Chief Executive Tim Davis and Chief Technology Officer Mike Hansen, benefits from a highly experienced senior management team. The company is headed by Executive Chairman Neil Rotherham, co-founder of ClinPhone, another clinical technology business which he steered from start up to a successful IPO on the London Stock Exchange, before it was acquired by Parexel, one of the world’s top contract research organisations.
SEP will support the company through its next growth phase, enabling it to invest further in people, technology and infrastructure and to further enhance its revolutionary mobile technology platform. Jan Rutherford, a Partner at SEP, joins Exco InTouch as a non-executive director. She brings on board a wealth of experience in providing strategic support to high growth companies in the healthcare sector as well as previous experience in working for Novartis and Quintiles.